INTANGIBLE ASSETS, NET - Narrative (Details) |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
|
Indefinite-lived Intangible Assets [Line Items] | ||||
Intangible asset impairment | $ 19,000,000 | $ 0 | ||
Deferred income tax (recovery) expense | (6,650,000) | 950,000 | ||
Finite-Lived Intangible Assets [Line Items] | ||||
Long-lived asset, impairment | 14,160,000 | 0 | ||
Amortization of intangible assets | 763,000 | $ 1,162,000 | ||
Finite-lived intangible assets, impairment charge | 0 | |||
Licenses | ||||
Indefinite-lived Intangible Assets [Line Items] | ||||
Indefinite-lived intangible assets acquired | $ 19,000,000 | |||
Intangible asset impairment | $ 19,000,000 | |||
Licenses | Discounted Future Cash Flow | Measurement Input, Weighted Average Cost of Capital | ||||
Indefinite-lived Intangible Assets [Line Items] | ||||
Intangible assets, measurement input | 0.22 | |||
Herbal Brands, Inc | ||||
Finite-Lived Intangible Assets [Line Items] | ||||
Finite-lived intangible assets acquired | $ 7,091,000 |
X | ||||||||||
- Definition Intangible Assets, Measurement Input No definition available.
|
X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|